ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246,734 | -19.0% | 316,325 | -3.9% | 0.15% | -14.7% |
| Q2 2023 | $304,468 | -13.0% | 329,155 | +2.5% | 0.18% | -18.8% |
| Q1 2023 | $350,059 | -19.2% | 321,155 | +8.2% | 0.22% | -25.6% |
| Q4 2022 | $433,240 | -7.6% | 296,740 | -31.9% | 0.29% | -30.9% |
| Q3 2022 | $469,000 | -33.7% | 435,985 | +4.8% | 0.42% | -38.5% |
| Q2 2022 | $707,000 | -18.4% | 416,166 | -1.0% | 0.69% | +0.7% |
| Q1 2022 | $866,000 | -13.2% | 420,447 | +58.0% | 0.68% | -17.0% |
| Q4 2021 | $998,000 | – | 266,048 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $5,165,000 | 4.93% |
| Long Focus Capital Management, LLC | 4,429,491 | $9,125,000 | 1.17% |
| Endurant Capital Management LP | 2,160,890 | $4,451,000 | 1.17% |
| NEA Management Company, LLC | 17,082,611 | $35,190,000 | 1.02% |
| Matrix Capital Management Company, LP | 38,974,185 | $80,287,000 | 0.96% |
| Key Client Fiduciary Advisors, LLC | 420,447 | $866,000 | 0.68% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $185,000 | 0.20% |
| DAFNA Capital Management LLC | 351,064 | $723,000 | 0.19% |
| PFM Health Sciences, LP | 2,374,674 | $4,892,000 | 0.18% |
| Rock Springs Capital Management LP | 2,297,194 | $4,732,000 | 0.12% |